WEEKLY e-ALERT  [ BASIC EDITION ]

Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies. Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China (Web Edition) as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.

Expert Opinions

	Investing in Government Affairs to Access Your Market Potential in China: Key Considerations(2/2/2012 )  (Premium)

Industry News

	Transgene steps up presence and R&D in China(1/31/2012 )  (Premium)

	MOH and Novo Nordisk forms government-private partnership for diabetes education(1/30/2012 )  (Premium)

Regulatory News

	CDE initiates regulation of clinical data management at its symposium for clinical data standards(1/30/2012 )  (Premium)

Legal/IPR News

	SFDA terminates administrative protection of two Roche products(2/1/2012 )  (Premium)

	Chinese expert calls for revision of the Drug Administration Law(1/31/2012 )  (Premium)

	Drug salesman and physicians sentenced to prison for corruption in Beijing(1/30/2012 )  (Premium)

People in the News

	Senior BMI official in Nanjing handed prison sentence for corruption(2/1/2012 )  (Premium)

	Recent executive moves(1/31/2012 )  (Premium)

© Wicon International Group　Support by: www.heightow.com	Home | Site map | Contact Us | Links